Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: A systematic review

Movement Disorders

Volumn 26, Issue 10, 2011, Pages 1939-1942

  Peall, Kathryn J ^a   Waite, Adrian J ^a   Blake, Derek J ^a   Owen, Mike J ^a   Morris, Huw R ^a  

^a Cardiff University   (United Kingdom)

Author keywords

DYT11; Epsilon sarcoglycan; Myoclonus dystonia; Psychiatric disorders; SGCE

Indexed keywords

ALCOHOL; EPSILON SARCOGLYCAN;

ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; DEPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; MAJOR AFFECTIVE DISORDER; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; MYOCLONUS DYSTONIA; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC);

DYSTONIC DISORDERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENTAL DISORDERS; MUTATION; SARCOGLYCANS;

EID: 80052294248     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23791     Document Type: Article

References (45)

1. Asmus F, Zimprich A, Tezenas Du Montcel S, et al. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol. 2002; 52: 489-492.
2. Doheny DO, Brin MF, Morrison CE, et al. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology. 2002; 59: 1187-1196.
3. Hess CW, Raymond D, Aguiar Pde C, et al. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology. 2007; 68: 522-524.
4. Saunders-Pullman R, Shriberg J, Heiman G, et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology. 2002; 58: 242-245.
5. Asmus F, Zimprich A, Naumann M, et al. Inherited Myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann Neurol. 2001; 49: 121-124.
6. Klein C, Schilling K, Saunders-Pullman RJ, et al. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet. 2000; 67: 1314-1319.
7. Nygaard TG, Raymond D, Chen C, et al. Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Ann Neurol. 1999; 46: 794-798.
8. Vidailhet M, Tassin J, Durif F, et al. A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q. Neurology. 2001; 56: 1213-1216.
9. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 2001; 29: 66-69.
10. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev. 2002; 82: 291-329.
11. Waite A, Tinsley CL, Locke M, Blake DJ. The neurobiology of the dystrophin-associated glycoprotein complex. Ann Med. 2009; 41: 344-359.
12. Grabowski M, Zimprich A, Lorenz-Depiereux B, et al. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet. 2003; 11: 138-144.
13. Muller B, Hedrich K, Kock N, et al. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet. 2002; 71: 1303-1311.
14. Asmus F, Hjermind LE, Dupont E, et al. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Brain. 2007; 130: 2736-2745.
15. Asmus F, Salih F, Hjermind LE, et al. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann Neurol. 2005; 58: 792-797.
16. Grunewald A, Djarmati A, Lohmann-Hedrich K, et al. Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat. 2008; 29: 331-332.
17. Saugier-Veber P, Doummar D, Barthez MA, et al. Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion. Am J Med Genet A. 2010; 152A: 1244-1249.
18. Kinugawa K, Vidailhet M, Clot F, Apartis E, Grabli D, Roze E. Myoclonus-dystonia: an update. Mov Disord. 2009; 24: 479-489.
19. Han F, Lang AE, Racacho L, Bulman DE, Grimes DA. Mutations in the epsilon-sarcoglycan gene found to be uncommon in seven myoclonus-dystonia families. Neurology. 2003; 61: 244-246.
20. Nardocci N, Zorzi G, Barzaghi C, et al. Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord. 2008; 23: 28-34.
21. Klein C, Brin MF, Kramer P, et al. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia. Proc Natl Acad Sci U S A. 1999; 96: 5173-5176.
22. Doheny D, Danisi F, Smith C, et al. Clinical findings of a myoclonus-dystonia family with two distinct mutations. Neurology. 2002; 59: 1244-1246.
23. Wong SH, Steiger MJ, Larner AJ, Fletcher NA. Hereditary myoclonus dystonia (DYT11): a novel SGCE gene mutation with intrafamilial phenotypic heterogeneity. Mov Disord. 2010; 25: 956-957.
24. Cohen-Cole SB, FW; McDaniel, JS. Assessment of Depression and Grief Reactions. New York: Oxford University Press; 1993.
25. O'Riordan S, Ozelius LJ, de Carvalho Aguiar P, Hutchinson M, King M, Lynch T. Inherited myoclonus-dystonia and epilepsy: further evidence of an association? Mov Disord. 2004; 19: 1456-1459.
26. Ritz K, Gerrits MC, Foncke EM, et al. Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry. 2009; 80: 653-658.
27. Beukers RJ, Booij J, Weisscher N, Zijlstra F, van Amelsvoort TA, Tijssen MA. Reduced striatal D2 receptor binding in myoclonus-dystonia. Eur J Nucl Med Mol Imaging. 2009; 36: 269-274.
28. Klein C, Liu L, Doheny D, et al. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. Ann Neurol. 2002; 52: 675-679.
29. Marechal L, Raux G, Dumanchin C, et al. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Am J Med Genet B Neuropsychiatr Genet. 2003; 119B: 114-117.
30. Misbahuddin A, Placzek M, Lennox G, Taanman JW, Warner TT. Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene. Mov Disord. 2007; 22: 1173-1175.
31. Koukouni V, Valente EM, Cordivari C, Bhatia KP, Quinn NP. Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer's cramp. Mov Disord. 2008; 23: 1913-1915.
32. Thummler S, Giuliano F, Pincemaille O, Saugier-Veber P, Perelman S. Myoclonus in fraternal twin toddlers: a French family with a novel mutation in the SGCE gene. Eur J Paediatr Neurol. 2009; 13: 559-561.
33. Hedrich K, Meyer EM, Schule B, et al. Myoclonus-dystonia: detection of novel, recurrent, and de novo SGCE mutations. Neurology. 2004; 62: 1229-1231.
34. Tezenas du Montcel S, Clot F, Vidailhet M, et al. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet. 2006; 43: 394-400.
35. Roze E, Apartis E, Clot F, et al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology. 2008; 70: 1010-1016.
36. Foncke EM, Gerrits MC, van Ruissen F, et al. Distal myoclonus and late onset in a large Dutch family with myoclonus-dystonia. Neurology. 2006; 67: 1677-1680.
37. Foncke EM, Cath D, Zwinderman K, Smit J, Schmand B, Tijssen M. Is psychopathology part of the phenotypic spectrum of myoclonus-dystonia?: a study of a large Dutch M-D family. Cogn Behav Neurol. 2009; 22: 127-133.
38. Kurtis MM, San Luciano M, Yu Q, et al. Clinical and neurophysiological improvement of SGCE myoclonus-dystonia with GPi deep brain stimulation. Clin Neurol Neurosurg. 2010; 112: 149-152.
39. Gruber D, Kuhn AA, Schoenecker T, et al. Pallidal and thalamic deep brain stimulation in myoclonus-dystonia. Mov Disord. 2010; 25: 1733-1743.
40. Oropilla JQ, Diesta CC, Itthimathin P, Suchowersky O, Kiss ZH. Both thalamic and pallidal deep brain stimulation for myoclonic dystonia. J Neurosurg. 2010; 112: 1267-1270.
41. Jog M, Kumar H. Bilateral pallidal deep brain stimulation in a case of myoclonus dystonia syndrome. Mov Disord. 2009; 24: 1547-1549.
42. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl. 1998: 26-37.
43. Olver JS, O'Keefe G, Jones GR, et al. Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder. J Affect Disord. 2009; 114: 321-326.
44. Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HG. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry. 2004; 55: 1041-1045.
45. Luciano MS, Ozelius L, Sims K, Raymond D, Liu L, Saunders-Pullman R. Responsiveness to levodopa in epsilon-sarcoglycan deletions. Mov Disord. 2009; 24: 425-428.